SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-010222
Filing Date
2020-04-03
Accepted
2020-04-03 17:59:21
Documents
2
Period of Report
2020-04-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1587
2 EX-24 DOCUMENT attachment1.htm EX-24 3477
  Complete submission text file 0000899243-20-010222.txt   6545
Mailing Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, LLC (Issuer) CIK: 0001725160 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ZENTALIS PHARMACEUTICALS,INC. 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address
Takhar Karan S. (Reporting) CIK: 0001807398 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39263 | Film No.: 20775116